Health Care: Health Services

WuXi PharmaTech (Cayman) Inc (WX: NYSE)

$34.11 -1.64 | -4.59%
09/19/14 - 04:08 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 578.08M 499.91M 407.18M 334.06M
Cost of Sales 321.78M 275.00M 216.74M 177.26M
Gross Operating Profit 256.30M 224.91M 190.44M 156.80M
Selling, General, and Administrative Expenses 95.37M 85.66M 72.63M 56.09M
Research & Development 10.95M 8.14M 0.00 0.00
Operating Income before D & A (EBITDA) 149.98M 131.12M 117.81M 100.71M
Depreciation & Amortization 44.74M 41.67M 34.00M 29.21M
Interest Income 11.49M 7.73M 6.06M 1.58M
Other Income - Net 23.25M 11.94M 8.51M 28.41M
Special Income / Charges 0.00 -3.42M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 139.98M 105.70M 98.38M 101.49M
Interest Expense 1.95M 1.72M 790.00K 436.00K
Pre-Tax Income 138.03M 103.98M 97.58M 101.06M
Income Taxes 23.46M 17.39M 16.61M 10.24M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 114.57M 86.58M 80.98M 90.81M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 114.57M 86.58M 80.98M 90.81M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 114.57M 86.58M 80.98M 90.81M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
114.57M 90.00M 80.98M 90.81M
Preferred Dividends
Net Income Available To Common 114.57M 86.58M 80.98M 90.81M
Basic EPS from Continuing Ops. 1.62 1.20 1.12 1.28
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.62 1.20 1.12 1.28
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.02 0.00 0.00 0.00
Basic EPS, Total 1.60 1.20 1.12 1.28
Basic Normalized Net Income/Share 1.62 1.25 1.12 1.28
EPS fr Continuing Ops. 1.57 1.20 1.04 1.20
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.57 1.20 1.04 1.20
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.03 0.00 0.00 0.00
EPS, Total 1.60 1.20 1.04 1.20
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.57 1.25 1.04 1.20
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with WX

Latest WX Headlines from TheStreet

More Financial News for WX

Press Releases for WX

See All Press Releases

Partner Headlines for WX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter